Business Daily Media

Men's Weekly

.

New coalition formed to fight heart disease across Asia

Patients, allied health professionals, academia, global health think-tank and corporate partners launch the Asia-Pacific Cardiovascular Disease Alliance (APAC CVD Alliance) to tackle heart disease in Asia

SINGAPORE - Media OutReach - 26 June 2023 - Today, patient organizations, allied health professionals, academia, corporate partners and a global health think-tank came together to launch the Asia-Pacific Cardiovascular Disease Alliance (APAC CVD Alliance), a multisectoral coalition committed to improving heart health and reducing the CVD burden across nine countries in Asia (Australia, China, India, Indonesia, Japan, Malaysia, South Korea, Thailand, Vietnam).


CVD is the leading cause of death in the Asia-Pacific, with the largest increase in premature deaths occurring in East Asia, South Asia, and Southeast Asia over the last 20 years. In 2019 alone, over 10 million people died of heart disease in Asia, making up 35% of all deaths in the region.

With four strategic partners – the Asia-Pacific Federation for Clinical Biochemistry and Laboratory Medicine (APFCB), Global Alliance for Patient Access (GAfPA), Global Heart Hub (GHH), and Universiti Teknologi MARA (UiTM) Faculty of Medicine in Malaysia – and corporate partners Amgen, Novartis, and Roche Diagnostics, the APAC CVD Alliance aims to:

  • Increase public and policy awareness of the importance of tackling CVD at regional and domestic forums in Asia;
  • Encourage implementation of scalable and sustainable CVD innovations across all health systems in Asia, and
  • Emphasize that investments to address CVD is much needed for healthy societies and productive economies.

Growing affluence, rapid urbanization, and aging populations in Asia present health systems with an increasing burden of CVD's direct and indirect costs and poor health outcomes.

"Accurate and rapid diagnoses for people with CVD are fundamental to all health systems", said Dr Tony Badrick, President, APFCB. "As the largest clinical biochemistry and laboratory federation in Asia, we have seen that investing in capacity building and education of laboratory professionals are essential for early detection and treatment of CVD and other non-communicable diseases. The APAC CVD Alliance's mandate to elevate policy awareness dovetails with the APFCB's goal of encouraging continual improvements to laboratory practices in the region."

"To tackle the rise of CVD in the region, we first have to confront the barriers that prevent patients from accessing quality cardiac management in their healthcare systems. Together with our alliance partners, Amgen aims to unify multi-sectorial efforts towards the common goal of recognizing and overcoming these challenges. Success for us means creating sustainable solutions that provide more effective, longer term care for patients in the region", said My Linh Kha, Senior Vice President and General Manager, Amgen Japan and Asia Pacific.

The APAC CVD Alliance will adopt a patient-centered approach across the entire CVD care continuum – prevention; early detection; treatment, cardiac rehabilitation, and step-down care.

Brian Kennedy, Executive Director, GAfPA said, "We are proud to partner the APAC CVD Alliance to advance patient engagement with clinicians and healthcare providers in the Asia-Pacific. With diverse stakeholders, we can ensure that patients' voices are heard and that policies are developed with the patient at the center."

"We are excited to join the APAC CVD Alliance to provide a global voice for those affected by CVD in Asia", added Neil Johnson, Executive Director, GHH. "As a long-time heart patient advocate, I believe we can make a real difference for patients and their families by partnering professionals and policymakers in Asia."

"According to the World Heart Federation, 80% of cardiovascular disease, including heart disease and stroke, is preventable. This is a shocking reality and calls for urgent action", said Iris Zemzoum, President, Novartis Asia Pacific, Middle East and Africa. "At Novartis, we envision a world where CVD is eliminated so patients can live longer and healthier lives. This alliance is a powerful example of forging sustainable partnerships across the healthcare ecosystem and working together to find innovative ways to unblock the barriers that stand in the way of heart health."

Building interdisciplinary, multisectoral partnerships are essential to unite CVD action across borders, especially with varied socio-economic and cultural diversity in the Asia-Pacific.

"CVD control cannot be accomplished with clinicians alone", said Associate Professor Dr Fazah Akhtar Hanapiah, Dean, Faculty of Medicine, UiTM. "The faculty has been working tirelessly in co-creating innovative solutions that bring together multidisciplinary healthcare professionals and other partners along the care continuum to prevent, treat, educate, and empower those living with CVD. Our academic, clinical and research background gives us that different edge in tackling the CVD crisis. We are excited to join the APAC CVD Alliance as a strategic partner, to improve patient well-being and care."

"A healthier, equitable future requires a renewed focus on chronic disease management and a willingness to look beyond physical symptoms. Chronic conditions such as heart disease come at a high personal cost to the person living with it, their families and communities. The Alliance provides an excellent platform to raise awareness around heart health. More importantly, it creates a collective opportunity to bring multiple voices that are critical to driving better healthcare for patients, lowering cost to society and creating a national push for greater access to cardiovascular disease innovations", said Lance Little, Head of Region, Asia Pacific, Roche Diagnostics Asia Pacific.

Based in Singapore as its regional hub for Southeast Asia, global health think-tank ACCESS Health International is the secretariat for the APAC CVD Alliance.

ACCESS Health International (Asia) President Dr Krishna Reddy said, "The Alliance aims to harness the existing good work in tackling CVD in the Asia-Pacific. ACCESS Health is proud to be the secretariat for this regional initiative and we look forward to improving investment in CVD innovations in policies, care models, products, or services across all health systems."

We are keen to work with more patients in Asia. We'd love to have a chat.

The Alliance is made possible with the support of Amgen, Novartis, and Roche Diagnostics. Read about our commitment to transparency.



Hashtag: #hearthealth



The issuer is solely responsible for the content of this announcement.

Asia-Pacific Cardiovascular Disease Alliance

The APAC CVD Alliance is a multisectoral, multistakeholder coalition dedicated to improving heart health for patients, societies, and economies by elevating public and policy awareness about CVD at regional and domestic forums in Asia.

Alliance strategic partners are the Asia-Pacific Federation for Clinical Biochemistry and Laboratory Medicine, the Global Alliance for Patient Access, the Global Heart Hub, and Universiti Teknologi MARA Faculty of Medicine, with Amgen, Novartis and Roche Diagnostics as corporate partners. ACCESS Health International is the secretariat for the Alliance based in Singapore.

News from Asia

Lee Kuan Yew School of Public Policy Releases Strategic Roadmap for ASEAN's 5G-AI Transformation

New Research Reveals US$130 Billion Economic Opportunity and Outlines Policy Framework to Accelerate Regional Digital Leadership by 2030SINGAPORE - Media OutReach Newswire - 22 July 2025 - The Le...

DFI Retail Group Holdings Limited Half-Year Results For The Six Months Ended 30 June 2025 And Announcement Of Special Dividend

Highlights 39% underlying earnings growth Increased contributions from associates, Health & Beauty and Food Health & Beauty delivered strong like-for-like (LFL...

HeyMax Acquires Hong Kong’s krip to Accelerate Regional Expansion into Loyalty and Rewards Market

HeyMax’s first acquisition fast-tracks its regional expansion, bringing over 6,000 credit card deals offered by over 3,000 merchants, and personalized loyalty experiences to consumers in Hong Kong ...

CUHK Faculty of Engineering: Advancing Innovation Through Research Excellence and Global Collaboration

HONG KONG SAR - Media OutReach Newswire - 23 July 2025 - The Faculty of Engineering at The Chinese University of Hong Kong (CUHK) continues to strengthen its position in global engineering educat...

Adecco Singapore Marks 40 Years of Enabling Talent and Business Growth

SINGAPORE - Media OutReach Newswire - 23 July 2025 - Adecco Singapore has officially commemorated its 40th anniversary with a stakeholder event held at the National Gallery Singapore. The occasion...

Samsung’s Solve for Tomorrow 2025 Youth Innovation Competition is Now On

SINGAPORE - Media OutReach Newswire - 23 July 2025 - Samsung Solve for Tomorrow 2025, the highly-anticipated youth innovation competition, is back for its ninth edition in Singapore! As the natio...

Jollibee Group Evolves its Corporate Brand to Help Power Global Growth

Brand update brings to life its global purpose and positioning as a unified group of brandsMANILA, PHILIPPINES - Media OutReach Newswire - 23 July 2025 - The Jollibee Group, one of the world's fas...

AECOM to enhance mobility across the Greater Bay Area by delivering the Hong Kong Section of Hong Kong–Shenzhen Western Rail Link (Hung Shui Kiu-Qianhai)

HONG KONG SAR - Media OutReach Newswire - 23 July 2025 - AECOM, the trusted global infrastructure leader, today announced that its joint venture with AtkinsRéalis has been awarded the consultancy ...

OCBC Hong Kong Unveils New Brand Campaign

Connected to “As One Group, OCBC Enables Aspiration All Across ASEAN and Greater China” Demonstrating the Unwavering Commitment in Realising Customer’s Aspirations HONG KONG SAR - Media...

X.me Foundation Empowers Global Expansion of the X.me Social Media Platform

SINGAPORE - Media OutReach Newswire - 23 July 2025 - X.me (https://x.me) is a social media platform where users can freely express themselves, share content, engage, and interact while earnin...

Baby boomers are driving development feasibility leading to larger apartments

As residential developers continue to grapple with feasibility issues on apartment projects, the sector is struggling to deliver volumes of new st...

Hays launches FY25/26 Salary Guide: ‘Salary Paradox’ deepens as pay rises fail Australians

Rising dissatisfaction with pay, progression and perks is fuelling a new wave of career change in FY25/26, as Australians demand more from employe...

Australian Businesses Still Stuck in the AI Hype Cycle

Data Governance Failures, ROI Gaps and Unclear Strategy Slowing Progress Despite artificial intelligence (AI) dominating headlines and boardroom ag...

How to ensure your manufacturing business survives international tariff turmoil

Optimising your operations in FY2026 will help you combat the challenges of a volatile trading environment. Up, down, in out…Since the commence...

Why Apptio is Enhancing Visibility into AI and Hybrid Cloud

AI investments have become a strategic priority for business with the mindset that if you're not using AI, you're falling behind. But according to...

Beyond borders: Building a scalable strategy for international hiring

For many Australian businesses, growth increasingly depends on thinking beyond local borders.  As wage pressures rise, and specialised talent pool...

Sell by LayBy